December 24, 2008 / 7:38 AM / 11 years ago

UPDATE 1-AstraZeneca says FDA requests Seroquel information

(Adds detail)

LONDON, Dec 24 (Reuters) - AstraZeneca (AZN.L) said the U.S. Food and Drug Administration (FDA) had requested further information relating to a supplemental new drug application for its schizophrenia drug Seroquel.

The Anglo-Swedish drugmaker said on Wednesday it was evaluating the contents of a so-called “complete response letter” from the FDA and proposed labelling revisions.

It said it will continue discussions with the FDA and provide a response to the agency in due course. (Reporting by Matt Scuffham)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below